Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer

Hänel W. Eberly; Bao Y. Sciscent; F. Jeffrey Lorenz; Eleni M. Rettig; Neerav Goyal

doi:10.3390/biomedicines12020415

Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer

Hänel W. Eberly
, Bao Y. Sciscent
, F. Jeffrey Lorenz
, Eleni M. Rettig
, Neerav Goyal

Research output: Contribution to journal › Review article › peer-review

24 Scopus citations

Abstract

Head and neck cancers (HNC) are a biologically diverse set of cancers that are responsible for over 660,000 new diagnoses each year. Current therapies for HNC require a comprehensive, multimodal approach encompassing resection, radiation therapy, and systemic therapy. With an increased understanding of the mechanisms behind HNC, there has been growing interest in more accurate prognostic indicators of disease, effective post-treatment surveillance, and individualized treatments. This chapter will highlight the commonly used and studied biomarkers in head and neck squamous cell carcinoma.

Original language	English (US)
Article number	415
Journal	Biomedicines
Volume	12
Issue number	2
DOIs	https://doi.org/10.3390/biomedicines12020415
State	Published - Feb 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Medicine (miscellaneous)
General Biochemistry, Genetics and Molecular Biology

Access to Document

10.3390/biomedicines12020415

Cite this

@article{c7447819140c4b3f83afb89f4dba2534,

title = "Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer",

abstract = "Head and neck cancers (HNC) are a biologically diverse set of cancers that are responsible for over 660,000 new diagnoses each year. Current therapies for HNC require a comprehensive, multimodal approach encompassing resection, radiation therapy, and systemic therapy. With an increased understanding of the mechanisms behind HNC, there has been growing interest in more accurate prognostic indicators of disease, effective post-treatment surveillance, and individualized treatments. This chapter will highlight the commonly used and studied biomarkers in head and neck squamous cell carcinoma.",

author = "Eberly, \{H{\"a}nel W.\} and Sciscent, \{Bao Y.\} and Lorenz, \{F. Jeffrey\} and Rettig, \{Eleni M.\} and Neerav Goyal",

note = "Publisher Copyright: {\textcopyright} 2024 by the authors.",

year = "2024",

month = feb,

doi = "10.3390/biomedicines12020415",

language = "English (US)",

volume = "12",

journal = "Biomedicines",

issn = "2227-9059",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "2",

}

TY - JOUR

T1 - Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer

AU - Eberly, Hänel W.

AU - Sciscent, Bao Y.

AU - Lorenz, F. Jeffrey

AU - Rettig, Eleni M.

AU - Goyal, Neerav

PY - 2024/2

Y1 - 2024/2

N2 - Head and neck cancers (HNC) are a biologically diverse set of cancers that are responsible for over 660,000 new diagnoses each year. Current therapies for HNC require a comprehensive, multimodal approach encompassing resection, radiation therapy, and systemic therapy. With an increased understanding of the mechanisms behind HNC, there has been growing interest in more accurate prognostic indicators of disease, effective post-treatment surveillance, and individualized treatments. This chapter will highlight the commonly used and studied biomarkers in head and neck squamous cell carcinoma.

AB - Head and neck cancers (HNC) are a biologically diverse set of cancers that are responsible for over 660,000 new diagnoses each year. Current therapies for HNC require a comprehensive, multimodal approach encompassing resection, radiation therapy, and systemic therapy. With an increased understanding of the mechanisms behind HNC, there has been growing interest in more accurate prognostic indicators of disease, effective post-treatment surveillance, and individualized treatments. This chapter will highlight the commonly used and studied biomarkers in head and neck squamous cell carcinoma.

UR - https://www.scopus.com/pages/publications/85187266432

UR - https://www.scopus.com/pages/publications/85187266432#tab=citedBy

U2 - 10.3390/biomedicines12020415

DO - 10.3390/biomedicines12020415

M3 - Review article

C2 - 38398017

AN - SCOPUS:85187266432

SN - 2227-9059

VL - 12

JO - Biomedicines

JF - Biomedicines

IS - 2

M1 - 415

ER -

Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this